European Alliance for
Newborn Screening in Spinal Muscular Atrophy

Opening a new horizon
for children born with spinal muscular atrophy

SMA: Screen at birth, save lives

Identifying children living with SMA through NBS allows for treatment to be started on time, preventing motor neuron death and a life with severe disability or even death.

Learn more about newborn screening for SMA in Europe

Find out more about the status of SMA screening in different countries


Download the latest versions of the SMA NBS Alliance materials

Quick facts about the Alliance and SMA Newborn Screening

IBIMA joins the SMA NBS Alliance

The European Alliance for SMA Newborn Screening is proud to welcome its newest partner organization the Biomedical Research Institute of Malaga (IBIMA). IBIMA is a cutting-edge centre of excellence in biomedicine and an accredited research institute in Malaga, Spain. IBIMA includes a multidisciplinary research space in which scientists from the university and health field work […]

The European Alliance for Newborn Screening in Spinal Muscular Atrophy demands that by 2025, newborn screening programmes in all European countries include a test for spinal muscular atrophy for all newborn children.